Primary record
BUTANEDIAMIDE, N(SUP 1)-(3-(3-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)OCTAHYDRO-2(1H)-ISOQUINOLINYL)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-2-((2-QUINOLINYLCARBONYL)AMINO)-, (3S-(2(1R*(R*),2S*),3.ALPHA.,4A.BETA.,8A.BETA.))-
- 库存
- 4,178 克
- 纯度
- 99.1 %
- CAS
- 127779-20-8
化合物标识与属性
- CAS
- 127779-20-8
- PubChem CID
- 441243
- SMILES
- CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
- Canonical SMILES
- CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1
名称与同义词
- SAQUINAVIR
- Fortovase
- Invirase
- saguinavir
- Saquinavirum
- 127779-20-8
- sequinavir
- Saquinavir mesylate
- Saquinivir
- Flunixine
- Fortovase(TM)
- Saquinavir/
- Saquinavir?
- Saquinavir mesilate
- Fortovase (TN)
- 1hxb
- 2fgu
- 2fgv
- Saquinavir [USAN]
- FLUNIXIN
- saquinaviri mesilas
- Invirase (TN)
- Saquinavir (Standard)
- PLCG-SQV
- L3JE09KZ2F
- NP-SQV
- CHEMBL114
- RefChem:57420
- SAQUINAVIR [MI]
- UNII-L3JE09KZ2F
- Invirase(TM)(monomesylate)
- AC1L9ATC
- SAQUINAVIR [INN]
- SAQUINAVIR [JAN]
- Prestwick0_001114
- Prestwick1_001114
- Prestwick2_001114
- Prestwick3_001114
- QNC-ASN-HPH-DIQ-NTB
- Ro 31-8959
- SAQUINAVIR [HSDB]
- saquinavir methanesulfonate
- Saquinavir (JAN/USP/INN)
- SAQUINAVIR [VANDF]
- CHEBI:63621
- D0WI3T
- SAQUINAVIR [MART.]
- SCHEMBL6881
- SAQUINAVIR [WHO-DD]
- SAQUINAVIR [WHO-IP]
- BIDD:PXR0010
- Sch 52852
- BDBM519
- BSPBio_001248
- DTXSID6044012
- Ro-31-8959
- HSDB 7161
- MLS001195635
- MLS001304735
- BIDD:GT0323
- Ro 318959
- SAQUINAVIR [EMA EPAR]
- SPBio_003114
- MFCD00866925
- SCH-52852
- BPBio1_001373
- C38H50N6O5
- GTPL4813
- Monomethanesulfonate, Saquinavir
- Saquinavir - Bio-X trade mark
- Saquinavir [USAN:USP:INN:BAN]
- SQV-poly(lactide-co-glycolide)
- DTXCID4024012
- SAQUINAVIR [ORANGE BOOK]
- SCHEMBL28019529
- SCHEMBL29357501
- Ro 31-8959/000
- J05AE01
- SAQUINAVIR [USP IMPURITY]
- NSC722663
- QWAXKHKRTORLEM-UGJKXSETSA-N
- HMS2232L04
- SAQUINAVIRUM [WHO-IP LATIN]
- ZINC3914596
- ABP000344
- BDBM50213021
- CID441243
- EBC-27425
- HY-17007R
- Ro 31 8959
- Saquinavir-poly(lactide-co-glycolide)
- saquinavirmesylate(subjecttopatentfree)
- AKOS000280831
- C38-H50-N6-O5
- Ro-31-8959/000
- ACN-029243
- CS-1180
- DB01232
- FS61498
- MRF-0000273
- NCGC00091469-02
- NCGC00091469-15
- AC-26377
- AN-32602
- BC210734
- BS164390
- Fortovase; SAQUINAVIR; RO 31-8959
- HY-17007
- SC-14020
- SMR000469157
- J378.898I
- LS-187081
- Ro-318959000
- A3790
- A3791
- AB00514056
- FT-0631125
- NS00007140
- (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide
- D00429
- W-5153
- 24223-EP2269989A1
- 24223-EP2272516A2
- 24223-EP2272825A2
- 24223-EP2298761A1
- 24223-EP2298783A1
- 24223-EP2305640A2
- 24223-EP2305680A2
- 24223-EP2314590A1
- 779S208
- A805746
- EN300-19767269
- Q422654
- BRD-K09963420-066-03-4
- (S)-N1-((2S,3R)-4-((3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-phenylbutan-2-yl)-2-(quinoline-2-carboxamido)succinamide
- (2S)-N-[(1S,2R)-3-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-1-benzyl-2-hydroxy-propyl]-2-(quinoline-2-carbonylamino)butanediamide
- 2-[[2-methyl-3-(trifluoromethyl)phenyl]amino]pyridine-3-carboxylic acid
- ROC
- SQV
- -phenyl-butan-2-yl]-2-(quinolin-2-ylcarbonylamino)butanediamide
- (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinolin-2-ylformamido)butanediamide
- (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-[(quinolin-2-yl)formamido]butanediamide
- Butanediamide, N1-(3-(3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1H)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (3S-(2(1R*(R*),2S*),3alpha,4aalpha,8aalpha))-
- Butanediamide, N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-, (2S)-
- CIS-N-TERT-BUTYL-DECAHYDRO-2-[2(R)-HYDROXY-4-PHENYL-3(S)-[[N-2-QUINOLYLCARBONYL-L-ASPARAGINYL]AMINO]BUTYL]-(4AS)-ISOQUINOLINE-3(S)-CARBOXAMIDE
- N(1)-{(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-3-hydroxy-1-phenylbutan-2-yl}-N(2)-(quinolin-2-ylcarbonyl)-L-aspartamide
- (2S)-N-[(2S,3R)-4-[(2S,3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1
- (2S)-N-[(2S,3R)-4-[(2S,3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1 -phenyl-butan-2-yl]-2-(quinolin-2-ylcarbonylamino)butanediamide
- (2s)-N-[(2s,3r)-4-[(2s,3s,4as,8as)-3-(Tert-Butylcarbamoyl)-3,4,4a,5,6,7,8,8a-Octahydro-1h-Isoquinolin-2-Yl]-3-Hydroxy-1-Phenyl-Butan-2-Yl]-2-(Quinolin-2-Ylcarbonylamino)butanediamide
- (3S)-N-tert-Butyl-2-[(2R,3S)-3-[N-(2-quinolinylcarbonyl)-3-carbamoylalanylamino]-2-hydroxy-4-phenylbutyl]-1,2,3,4,4abeta,5,6,7,8,8abeta-decahydroisoquinoline-3alpha-carboxamide
- (3S-(2(1R*(R*),2S*),3I,4athetav,8athetav))-N(sup 1)-(3-(3-(((1,1-Dimethylethyl)amino)carbonyl)octahydro-2(1H)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)butanediamide
- (4aS,8abeta)-N-tert-Butyldecahydro-2-[(2R,3S)-2-hydroxy-4-phenyl-3-[[(2S)-3-carbamoyl-2-(2-quinolinylcarbonylamino)propanoyl]amino]butyl]isoquinoline-3alpha-carboxamide
- (S)-N-((.ALPHA.S)-.ALPHA.-((1R)-2-((3S,4AS,8AS)-3-(TERT-BUTYLCARBAMOYL)OCTAHYDRO-2(1H)-ISOQUINOLYL)-1-HYDROXYETHYL)PHENETHYL)-2-QUINALDAMIDOSUCCINAMIDE
- (S)-N-((IS)-I-((1R)-2-((3S,4aS,8aS)-3-(tert-Butylcarbamoyl)octahydro-2(1H)-isoquinolyl)-1-hydroxyethyl)phenethyl)-2-quinaldamidosuccinamide
- (S)-N-[(IS)-I-[(1R)-2-[(3S,4aS,8aS)-3-(tert-Butylcarbamoyl)octahydro-2(1H)-isoquinolyl]-1-hydroxyethyl]phenethyl]-2-quinaldamidosuccinamide
- 149845-06-7
- BUTANEDIAMIDE, N(SUP 1)-(3-(3-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)OCTAHYDRO-2(1H)-ISOQUINOLINYL)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-2-((2-QUINOLINYLCARBONYL)AMINO)-, (3S-(2(1R*(R*),2S*),3.ALPHA.,4A.BETA.,8A.BETA.))-
- Butanediamide, N1-((1S,2R)-3-((3S,4aS,8aS)-3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1H)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (2S)-
- N(1)-((2S,3R)-4-((3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-phenylbutan-2-yl)-N(2)-(quinolin-2-ylcarbonyl)-L-aspartamide
- N-tert.butyl-decahydro -2- [2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl) -L-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide
- N-tert.butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl)-L-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide
- N-tert.butyl-decahydro-2[2(R)-hydroxy-4-phenyl-3-(S)-[[N-(2-quinolylcarbonyl)-L-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide
- N~1~-{(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-3-hydroxy-1-phenylbutan-2-yl}-N~2~-(quinolin-2-ylcarbonyl)-L-aspartamide
- N~1~-{(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-Butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-3-hydroxy-1-phenylbutan-2-yl}-N~2~-(quinoline-2-carbonyl)-L-aspartamide
- N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-Dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-butanediamide